Drug interactions
Armodafinil + Selegiline transdermal
Severity: Major
Armodafinil and Selegiline transdermal: major interaction.
Last updated Sources: US FDA label
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Transdermal selegiline provides systemic MAO inhibition at antidepressant doses. Armodafinil is a stimulant, and the combination may raise blood pressure and cause hypertensive reactions.
What this interaction means in plain words
Armodafinil and Selegiline transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
MAO inhibition combined with armodafinil's dopaminergic and noradrenergic effects may produce additive pressor responses.
What to do
Avoid unless benefit clearly outweighs risk; if combined, monitor blood pressure closely, especially after dose changes.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Selegiline transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
References
Other interactions of Armodafinil
Frequently asked questions
Can I take Armodafinil with Selegiline transdermal?
MediHelp rates the interaction as major. Armodafinil and Selegiline transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Transdermal selegiline provides systemic MAO inhibition at antidepressant doses. Armodafinil is a stimulant, and the combination may raise blood pressure and cause hypertensive reactions.
How serious is the interaction between Armodafinil and Selegiline transdermal?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid unless benefit clearly outweighs risk; if combined, monitor blood pressure closely, especially after dose changes.
What other medicines interact with Armodafinil?
MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
